Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of intra-erythrocyte dexamethasone sodium phosphate on neurological symptoms in ataxia telangiectasia
2010-022315-19Phase 2Completed
- Sponsor
- EryDel S.p.A.
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dexamethasone sodium phosphate in ataxia-telangiectasia (AT), sponsored by EryDel S.p.A. Primary endpoint: ICARS improvement at 6 months. Started Dec 2010; status: completed.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on 2010-022315-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022315-19.